BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36094595)

  • 1. Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type.
    Fukagawa K; Takahashi Y; Yamamichi N; Kageyama-Yahara N; Sakaguchi Y; Obata M; Cho R; Sakuma N; Nagao S; Miura Y; Tamura N; Ohki D; Mizutani H; Yakabi S; Minatsuki C; Niimi K; Tsuji Y; Yamamichi M; Shigi N; Tomida S; Abe H; Ushiku T; Koike K; Fujishiro M
    Gastric Cancer; 2023 Jan; 26(1):44-54. PubMed ID: 36094595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the thyroid transcription factor gene NKX2-1 result in decreased expression of SFTPB and SFTPC.
    Attarian SJ; Leibel SL; Yang P; Alfano DN; Hackett BP; Cole FS; Hamvas A
    Pediatr Res; 2018 Sep; 84(3):419-425. PubMed ID: 29538355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.
    Matsubara D; Soda M; Yoshimoto T; Amano Y; Sakuma Y; Yamato A; Ueno T; Kojima S; Shibano T; Hosono Y; Kawazu M; Yamashita Y; Endo S; Hagiwara K; Fukayama M; Takahashi T; Mano H; Niki T
    Cancer Sci; 2017 Sep; 108(9):1888-1896. PubMed ID: 28677170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty cases of gastric adenocarcinoma of the fundic gland type.
    Yang M; Sun X; Chen Y; Yang P
    Scand J Gastroenterol; 2023 Jul; 58(7):744-750. PubMed ID: 36604805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance.
    Sano K; Hayashi T; Suehara Y; Hosoya M; Takamochi K; Kohsaka S; Kishikawa S; Kishi M; Saito S; Takahashi F; Kaneko K; Suzuki K; Yao T; Ishijima M; Saito T
    J Pathol Clin Res; 2021 Jul; 7(4):361-374. PubMed ID: 34014042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings.
    Chiba T; Kato K; Masuda T; Ohara S; Iwama N; Shimada T; Shibuya D
    Dig Endosc; 2016 Nov; 28(7):722-730. PubMed ID: 27129734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic endoscopic findings of gastric adenocarcinoma of fundic-gland mucosa type.
    Imamura K; Yao K; Nimura S; Tanabe H; Kanemitsu T; Miyaoka M; Ono Y; Ueki T; Iwashita A
    Gastric Cancer; 2021 Nov; 24(6):1307-1319. PubMed ID: 34241719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric adenocarcinoma of fundic gland mucosa type localized in the submucosa: A case report.
    Uchida A; Ozawa M; Ueda Y; Murai Y; Nishimura Y; Ishimatsu H; Okouchi Y; Ishiguro K; Hamada Y; Sasamoto R; Watanabe M; Sano N; Miyamoto R; Inagawa S; Kikuchi K
    Medicine (Baltimore); 2018 Sep; 97(37):e12341. PubMed ID: 30212986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type.
    Ueyama H; Yao T; Akazawa Y; Hayashi T; Kurahara K; Oshiro Y; Yamada M; Oda I; Fujioka S; Kusumoto C; Fukuda M; Uchita K; Kadota T; Oono Y; Okamoto K; Murakami K; Matsuo Y; Kato M; Maehata T; Yahagi N; Yasuhara Y; Yada T; Uraushihara K; Yamane T; Matsuo T; Ito M; Maruyama Y; Osako A; Ono S; Kato M; Yagi K; Hashimoto T; Tomita N; Tsuyama S; Saito T; Matsumoto K; Matsumoto K; Watanabe S; Uemura N; Chiba T; Nagahara A
    J Gastroenterol; 2021 Sep; 56(9):814-828. PubMed ID: 34268625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature.
    Kai K; Satake M; Tokunaga O
    World J Gastroenterol; 2018 Jul; 24(26):2915-2920. PubMed ID: 30018486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
    Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
    J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features.
    Miyazawa M; Matsuda M; Yano M; Hara Y; Arihara F; Horita Y; Matsuda K; Sakai A; Noda Y
    World J Gastroenterol; 2016 Dec; 22(48):10523-10531. PubMed ID: 28082804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pathological characteristics of 4 cases of gastric gland-derived tumors].
    Wang CC; Gu J; Jiang BB; Cao RX; Liu XH
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):781-786. PubMed ID: 34289573
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
    Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric adenocarcinoma of fundic gland type spreading to heterotopic gastric glands.
    Manabe S; Mukaisho KI; Yasuoka T; Usui F; Matsuyama T; Hirata I; Boku Y; Takahashi S
    World J Gastroenterol; 2017 Oct; 23(38):7047-7053. PubMed ID: 29097877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TTF-1/Nkx2.1 functional connection with mutated EGFR relies on LRIG1 and β-catenin pathways in lung cancer cells.
    Zamboni M; Civitareale D
    Biochem Biophys Res Commun; 2018 Nov; 505(4):1027-1031. PubMed ID: 30314701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing.
    Zhang M; Hu S; Min M; Ni Y; Lu Z; Sun X; Wu J; Liu B; Ying X; Liu Y
    Gut; 2021 Mar; 70(3):464-475. PubMed ID: 32532891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of lung adenocarcinoma progression by Nkx2-1.
    Winslow MM; Dayton TL; Verhaak RG; Kim-Kiselak C; Snyder EL; Feldser DM; Hubbard DD; DuPage MJ; Whittaker CA; Hoersch S; Yoon S; Crowley D; Bronson RT; Chiang DY; Meyerson M; Jacks T
    Nature; 2011 May; 473(7345):101-4. PubMed ID: 21471965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.
    Yamaguchi T; Hosono Y; Yanagisawa K; Takahashi T
    Cancer Cell; 2013 Jun; 23(6):718-23. PubMed ID: 23763999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
    Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA
    J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.